Skip to content

    Anupam Rasayan

    ANURAS
    Chemicals·15 Dec 2025
    Management Summary

    Anupam Rasayan announced the strategic acquisition of Jayhawk Fine Chemicals for USD150 million, significantly enhancing its global presence with direct US manufacturing capabilities. This move is expected to be EPS-accretive from day one, leveraging Jayhawk's USD78 million CY24 revenue and ~19% EBITDA margins to create a pro-forma entity with USD243 million revenue and USD61 million EBITDA. The acquisition aligns with Anupam's strategy to build an integrated specialty and CDMO platform, expanding into high-value end markets and strengthening customer relationships.

    Highlights

    5
    • Acquisition of Jayhawk Fine Chemicals, a US-based specialty chemicals company, strengthens global footprint and provides direct US manufacturing presence.

    • Jayhawk reported USD78 million revenue in CY24 with approximately 19% EBITDA margins.

    • The acquisition is expected to be EPS-accretive from day one.

    • Pro-forma combined entity is projected to have USD243 million revenue and USD61 million EBITDA.

    • Enhances access to fast-growing innovation-led end markets like semiconductors, automotive, EV, aviation, and electronics.

    Key financials

    Metrics

    6

    Periods

    2

    Headline

    5
    • Jayhawk Revenue (CY24)
      78 Mn
    • Jayhawk EBITDA Margin (CY24)
      19%
    • Combined Pro-forma Revenue
      243 Mn
    • Combined Pro-forma EBITDA
      61 Mn
    • Acquisition Enterprise Value
      134 Mn

    Q2

    1
    • Anupam Net Debt
      ₹730 Cr

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Net ₹730 crores

    M&A

    Jayhawk Fine Chemicals

    acquisition · signed · Consideration ₹NaN (mixed)

    Guidance & targets

    4
    CategoryTargetPriority
    Profitability
    EPS Accretion
    Accretive from day one
    High
    Margin
    Combined Entity EBITDA Margin
    No effective dilution
    Medium
    Revenue Growth
    Anupam Standalone Agro Business Revenue
    Significant increase
    Medium
    Growth
    Jayhawk Growth
    Similar to Anupam's historical growth rates
    Medium

    Jayhawk Acquisition Closing

    January
    CurrentSigned definitive agreement on Dec 9, 2025
    TargetAcquisition closed

    Why it matters

    Essential for realizing all stated strategic and financial benefits of the acquisition.

    Its closing is going to be in January. It will be in the second half of January.

    How to verify

    capital_allocation.m_and_a[target='Jayhawk Fine Chemicals'].status

    0

    Q&A highlights

    8

    “one of the biggest one is basically it helps us strengthen our presence in US. This acquisition marks Anupam's entry into onshore manufacturing in the United States, which perfectly aligns with our global expansion strategy to be a global player, global CDMO player for our customers.”

    Clearly outlines the core strategic benefits and global expansion vision, emphasizing US onshore manufacturing and CDMO capabilities.

    asked by Anshuman Gupta

    2 min read5 chapters

    Detailed Narrative

    01

    Acquisition Rationale and Strategic Fit

    Anupam Rasayan announced the acquisition of Jayhawk Fine Chemicals, a US-based specialty chemicals company, on December 9, 2025. This strategic move aims to establish a direct onshore manufacturing presence in the United States, enhancing engagement with multinational customers and strengthening the company's global specialty footprint. The acquisition expands Anupam's access to fast-growing innovation-led end markets such as semiconductors, automotive, EV, aviation, and electronics, and is fully aligned with the strategy to build a global integrated specialty and CDMO platform.

    02

    Financial Impact and Funding Structure

    Jayhawk reported USD78 million in revenue for CY24 with an EBITDA margin of approximately 19%. The acquisition, valued at an enterprise value of USD134 million (9x CY24 EBITDA), is expected to be EPS-accruing from day one. The total purchase consideration is USD150 million, with Anupam Rasayan investing USD40 million through a combination of internal accruals and debt. The remaining USD110 million will be funded by a global investment management firm via Class B non-voting shares, allowing Anupam to fully consolidate Jayhawk.

    03

    Operational Synergies and Growth Outlook

    The combined entity is projected to have pro-forma revenues of USD243 million and EBITDA of USD61 million. Jayhawk's product portfolio, with 65% from performance materials, complements Anupam's existing strengths, creating a diversified mix of agrochem (40-45%), performance material (35%), and personal care/pharma (20%). Management expects no effective margin dilution for the combined entity over the next two to three years, and aims for Jayhawk to achieve growth rates similar to Anupam's historical performance over the next 3-4 years.

    04

    Customer Reception and Supply Chain Integration

    The acquisition has been met with positive feedback from customers of both Anupam and Jayhawk, who are excited about the prospect of an integrated supply chain solution. The combined entity will offer greater supply chain stability and flexibility, with Anupam acting as a cost-efficient, backward-integrated manufacturing base and Jayhawk providing advanced technology and customer proximity in the US. This dual-site model is expected to deepen customer relationships and provide a one-stop solution for critical customer needs.

    05

    Integration Strategy and Past Success

    Anupam Rasayan plans to integrate Jayhawk by initially focusing on scaling existing products and selectively expanding capacity, leveraging the 80% available land at Jayhawk's 3 million square meter facility. The company draws confidence from its successful integration of Tanfac, where capacity doubled, revenue grew 3x, and EBITDA margins increased by 50-75% within 3.5 years. Anupam will continue to use external consulting firms to ensure a smooth integration process for Jayhawk, which has an independent and capable management team.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.